Alessandro Vitello, Mauro Grova, Daniela Pugliese, Fernando Rizzello, Francesco Lanzarotto, Alessandro Lavagna, Roberta Caccaro, Maria Cappello, Anna Viola, Davide Giuseppe Ribaldone, Mariabeatrice Principi, Elisa Stasi, Maria Lia Scribano, Marcello Maida, Alessandra Soriano, Cristina Bezzio, Giorgia Bodini, Filippo Mocciaro, Antonio Carlo Privitera, Daniele Simondi, Enrica Giuffrida, Renata D'Incà, Chiara Ricci, Paolo Gionchetti, Alessandro Armuzzi, Ambrogio Orlando, Marco Daperno
BACKGROUND: Adalimumab is used to treat ulcerative colitis, but additional effectiveness and safety data are needed. PATIENTS AND METHODS: This retrospective study considered adults with ulcerative colitis treated with adalimumab at 19 hospitals. Clinical data were collected from the start of treatment, after 2, 6 and 12 months, and at the last visit. Outcome measures of effectiveness were treatment duration, reasons for discontinuation and colectomy. RESULTS: We studied 381 patients treated with adalimumab for a median of 12...
March 2022: Digestive and Liver Disease